PRISM (Drug Discovery) Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 4

PRISM (Drug Discovery) General Information

Description

Provider of therapeutic treatment for non-oncology indications. The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases, enabling medical practitioners to help people to cure their diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2-26 Muraokahigashi
  • Kanagawa Prefecture 251-0012 Shonan Eye Park
  • Fujisawa, 251-0012
  • Japan
+81 0000-00-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PRISM (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 13-Jun-2013 $15M 0000 Completed Generating Revenue
2. Early Stage VC (Series B) Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view PRISM (Drug Discovery)’s complete valuation and funding history, request access »

PRISM (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of therapeutic treatment for non-oncology indications. The company develops therapeutic agents that are used to
Drug Discovery
Fujisawa, Japan
0000
00000000000 0000

000000 0

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00

0000000

illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000000000000
Monmouth Junction, NJ
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PRISM (Drug Discovery) Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
0000000 Corporation Monmouth Junction, NJ 00 00000 00000000 00000
0000000-00000 0000 Corporation New York, NY 00000 00000 000000000 00000
000 Corporation Brussels, Belgium 0000 00000 000000 - 000 00000
To view PRISM (Drug Discovery)’s complete competitors history, request access »

PRISM (Drug Discovery) Executive Team (5)

Name Title Board Seat Contact Info
Dai Takehara Co-Chief Executive Officer, President & Board Member.
Hiroyuki Kouji Ph.D Founder, Co-Chief Executive Officer, President & Board Member
Shingo Nakamura Board Member & Outside Director
Tetsushi Inada Ph.D Executive Vice President, Global Development and Alliance
You’re viewing 4 of 5 executive team members. Get the full list »

PRISM (Drug Discovery) Board Members (6)

Name Representing Role Since
Dai Takehara PRISM (Drug Discovery) Co-Chief Executive Officer, President & Board Member. 000 0000
Hiroyuki Kouji Ph.D PRISM (Drug Discovery) Founder, Co-Chief Executive Officer, President & Board Member 000 0000
Koichi Ashida PRISM (Drug Discovery) Board Member & Outside Director 000 0000
Shingo Nakamura PRISM (Drug Discovery) Board Member & Outside Director 000 0000
Yasuhisa Yamaguchi PRISM (Drug Discovery) Board Member & Outside Director 000 0000
You’re viewing 5 of 6 board members. Get the full list »

PRISM (Drug Discovery) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DBJ Capital Corporate Venture Capital Minority 000 0000 000000 0
Development Bank of Japan Corporation Minority 000 0000 000000 0
Innovation Network Corporation of Japan Venture Capital Minority 000 0000 000000 0
Nissay Capital Venture Capital Minority 000 0000 000000 0
To view PRISM (Drug Discovery)’s complete investors history, request access »